BackConcert Pharmaceuticals Overview

Concert Pharmaceuticals Total Revenue

Revenue analysis for CNCE.

Quarterly Revenue

$8000.00
↓ 98.53% YoY

As of Sep 2022

Annual Revenue (TTM)

$56578.00
↓ 99.83% YoY

Trailing 12 months ending Sep 2022

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin